Company performance
Current Price
as of Jan 23, 2025$1.39
P/E Ratio
N/A
Market Cap
$71.93M
Description
PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.
Metrics
Overview
- HQPrinceton, NJ
- SectorHealth Technology
- IndustryBiotechnology
- TickerPMVP
- Price$1.39+5.30%
Trading Information
- Market cap$71.93M
- Float84.57%
- Average Daily Volume (1m)181,494
- Average Daily Volume (3m)193,474
- EPS-$1.00
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$19.23M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$21.52M
- EV-$93.55M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B0.36
Documents
SEC Filings
Factset Street Account